Rousselot STABICAPS™, the proven solution for more stable soft gels

Product description

When manufacturing soft gels, nutra- and pharmaceutical manufacturers sometimes experience shell cross-linking leading to stability issues. With StabiCaps, such stability issues can be overcome.  Building on its extensive in-house research, Rousselot has developed a range of gelatins with superior performance in terms of soft gel stability and resistance to crosslinking; this patented technology is commercialized under the name StabiCaps and has been specifically designed to offer a low viscosity profile and pH range, both necessary qualities to reduce crosslinking in soft capsule formulation.
StabiCaps is the perfect solution for the most reactive fills, offering:
- Reduced maturation time and faster drying time, improving production efficiency
- Perfect protection of active ingredients
- Optimal behavior in the presence of cross-linkers- Optimal shell stability and shelf-life
- Optimal dissolution and API releaseMore on

Read more


Categories Pharmaceutical Ingredients
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
End-Use Categories Pharmaceutical
Certifications Halal; Kosher

More products from ROUSSELOT SAS

View all our products (10)

Products from other suppliers